Home > Boards > US OTC > Biotechs >

Vivakor, Inc. (VIVK)

VIVK RSS Feed
Add VIVK Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Atlanta1
Search This Board:
Last Post: 6/27/2014 2:02:41 AM - Followers: 70 - Board type: Free - Posts Today: 0

 

Vivakor Inc. 

Overview:

Vivakor, Inc. is a biotechnology holding company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life.

Mission:

Vivakor is Inventing Solutions for Life. Vivakor is dedicated to advancing new ideas that improve life for the individual patient, researcher, clinician, and consumer. We don't create science in a vacuum; we push products to market. Our model of innovation spans the continuum from ideas conception to commercialization. We create solutions that positively impact life.

Business Overview:

Vivakor, Inc. ("Vivakor," the "Company," or "we") is a transdisciplinary research company that develops products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds. We also provide contract research services for third parties. We have developed numerous products and have filed many patents or provisional patents with the United States Patent and Trademark Office (USPTO). We intend to commercialize such products, after completion of any required regulatory approvals, through one of three methods: a sale of the technology, licensing of the product to a manufacturer or distributor or, in some cases, by manufacturing, marketing and directly selling the products ourselves.

Our business model is to be a research hub focused on areas that have both an identified scientific need and a substantial market opportunity. Our company mission is to advance new ideas to improve the quality of life for individual patients, researchers, clinician or consumer. We believe that the development of substantive technologies and cures for complex human conditions, illnesses and diseases require a sophisticated approach with contribution from many areas of scientific expertise typically requiring a lengthier trajectory to market. Our hub approach is intended to provide the necessary environment of transdisciplinary collaboration and cross-pollination to advance this type of research. Our research is anchored by our relationship with collaborative partners and product-specific commercialization strategies. From the commencement of product conception through development, we target specific commercialization strategies and expect to have collaborative partners or licensing arrangements in place for each of our products before completion. We expect this model to offer several advantages to our shareholders, including a more efficient research and development process and a quicker time to market after completion of development.

Our pathway for development of products follows one of two routes to commercialization. First is a short-term path in which products for which an expedited regulatory oversight is available are rapidly pushed to the prototype and alpha testing phase. These projects represent rapidly commercializable technologies and products that we expect will have the potential to generate revenue quickly. Second is a long-term path in which more involved and complex projects are developed. These products typically require substantial regulatory oversight or approval. We anticipate that cash flow generated by the short-term projects will help to fund the long-term projects. These longer incubating projects characteristically represent breakthrough technologies with more risk but higher revenue potential.

 

 

News: http://ir.stockpr.com/vivakor/news-room

SEC Filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001450704&type=&dateb=&owner=include&count=40

Website: http://www.vivakor.com/

Matthew Nicosia

Executive Chairman

Matthew Nicosia has served as a director of our Company since November, 2006.  From 2000 to 2007, prior to joining the Company as Executive Chairman of the Board, Mr. Nicosia was the founder and Chief Executive Officer and served as a director of Dermacia, Inc. While founding Dermacia, Inc., in 2002, Mr. Nicosia, co-founded Quantum Sphere, Inc. and served as a director till 2004.  Mr. Nicosia also currently sits on the Board of Directors and is a principal of Integrity, Equity, and is a director of several private companies. Mr. Nicosia received his Bachelor of Arts degree from Brigham Young University and an MBA degree from Pepperdine University.

 

 

Empire Stock Transfer Inc.
Corporate Office:
1859 Whitney Mesa Dr
Henderson, NV 89014

Tel: 702-818-5898

 

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VIVK
Current Price
Volume:
Bid Ask Day's Range
Wiki
VIVK News: Vivakor Eagerly Expands Natural Resources Operational Focus 06/26/2014 11:13:00 AM
VIVK News: Vivakor Unveils Scaled-Up Precious Metals Extraction Machine 06/04/2014 06:32:51 PM
VIVK News: Vivakor Exceeds Estimates, Announces 1st Quarter 2014 Results 05/19/2014 09:49:01 PM
VIVK News: A New Audio Interview With Matt Nicosia, Chairman and CEO of Vivakor Inc., is Now at SmallCapVoice.com 04/30/2014 08:00:00 AM
VIVK News: Vivakor Exceeds Expectations on Metals Production for Q1 2014 From Metals Division 04/17/2014 08:54:45 PM
PostSubject
#7087  Sticky Note DON'T BE BAMBOOZLED. Atlanta1 04/28/14 10:12:29 AM
#7662   This stock will make another nice run here audi65 06/27/14 02:02:41 AM
#7661   Slickosia out with another ridiculous fluff PR today. Atlanta1 06/26/14 11:17:29 AM
#7660   Finally some movement upwards!! This could be audi65 06/12/14 09:59:19 AM
#7659   Yea, and am I now to assume these ipulator_man 06/02/14 12:38:06 AM
#7658   VIVK is a joke. Atlanta1 06/01/14 06:04:48 AM
#7657   This has got to be the biggest ipulator_man 06/01/14 05:31:57 AM
#7656   Wondering if the pref B shareholders, are just richrichrich 05/07/14 08:49:59 PM
#7655   The latest filing the 10K Annual Report on fast.money 05/02/14 03:38:46 PM
#7654   The positive momentum in production output will continue budfoxhub 05/02/14 03:30:43 PM
#7653   Fri, 18 Apr 2014 00:54:45 GMT ~ Vivakor Cabroncita 05/02/14 03:02:26 PM
#7652   Weekly Chart Golden Cross: budfoxhub 05/02/14 02:46:40 PM
#7651   Vivakor’s International technology holding division holds technologies in Cabroncita 05/02/14 02:42:16 PM
#7650   $VIVK also effectively acquired the assets (patents and fast.money 05/02/14 02:28:09 PM
#7649   $VIVK has an Active Status on the Nevada SOS: Cabroncita 05/02/14 02:19:14 PM
#7648   Lots of activity this week for $VIVK on stockman69 05/02/14 02:11:43 PM
#7647   Vivakor, Inc. (VIVK) is an Asset Acquisition company stockman69 05/02/14 02:11:28 PM
#7646   UNCOMPENSATED AWARENESS POST Atlanta1 05/02/14 01:59:37 PM
#7645   Great DD here: http://www.ddnotesmaker.com/index.php?ticker=vivk Cabroncita 05/02/14 01:52:10 PM
#7644   SEC Filings http://www.barchart.com/plmodules/?module=secFilings&symbol=VIVK Cabroncita 05/02/14 01:51:43 PM
#7643   $VIVK has effectively acquired positions in other Green fast.money 05/02/14 01:50:51 PM
#7642   $VIVK http://finance.yahoo.com/q/h?s=VIVK+Headlines budfoxhub 05/02/14 01:40:19 PM
#7641   If we can just get close to breaking Affix Trader 05/02/14 01:32:45 PM
#7640   With the great updates we've seen lately, I Affix Trader 05/02/14 01:32:05 PM
#7639   VIVK on watch next week for further company updates stockman69 05/02/14 01:27:51 PM
#7638   Looking to push through some of these .45's stockman69 05/02/14 01:27:40 PM
#7637   Shorters are scared to touch $VIVK because they Affix Trader 05/02/14 01:23:58 PM
#7636   Learn about the management of $VIVK right here Affix Trader 05/02/14 01:21:15 PM
#7635   Only 203,135,860 shares outstanding means that $VIVK can Affix Trader 05/02/14 01:20:37 PM
#7634   Biotechnology areas of research and acquisition are molecular fast.money 05/02/14 01:11:17 PM
#7633   As a holding company, Vivakor provides public and budfoxhub 05/02/14 01:07:59 PM
#7632   UNCOMPENSATED AWARENESS POST Atlanta1 05/02/14 12:54:30 PM
#7631   Financial Reporting/Disclosure fast.money 05/02/14 12:51:19 PM
#7630   They've exceeded their own expectations recently - what Affix Trader 05/02/14 12:49:50 PM
#7629   Here's the DDNotesMaker report for $VIVK Affix Trader 05/02/14 12:48:41 PM
#7628   The addition of metals extraction units this year stockman69 05/02/14 12:45:40 PM
#7627   Vivakor targets developing companies focused on bringing new budfoxhub 05/02/14 12:44:59 PM
#7626   $VIVK http://vivakor.com/ budfoxhub 05/02/14 12:44:47 PM
#7625   Higher production output increases asset growth, and our stockman69 05/02/14 12:44:47 PM
#7624   Absolutely, and that transparency adds a lot in Affix Trader 05/02/14 12:40:29 PM
#7623   More DD Links !!! fast.money 05/02/14 12:20:45 PM
#7622   Agreed, VIVK does a great job of keeping stockman69 05/02/14 12:20:12 PM
#7621   The company has been releasing a steady flow Affix Trader 05/02/14 12:08:18 PM
#7620   Volume has been trending up here, which means Affix Trader 05/02/14 12:07:03 PM
#7619   This might be the highest CMF I've ever Affix Trader 05/02/14 12:06:09 PM
#7618   Short Interest & RegSho Data: fast.money 05/02/14 11:59:04 AM
#7617   Seeing so many closes at .45 in a Affix Trader 05/02/14 11:57:54 AM
#7616   If you're looking for more good DD on Affix Trader 05/02/14 11:55:17 AM
#7615   $VIVK http://finance.yahoo.com/news/vivakor-exceeds-expectations-metals-producti budfoxhub 05/02/14 11:36:44 AM
#7614   Sentiment is becoming increasingly bullish here on social Affix Trader 05/02/14 11:32:23 AM
#7613   Thanks for the link to the company website, Affix Trader 05/02/14 11:31:49 AM
PostSubject